Since DNA methylation can control gene expression without causing any alteration in the genomic sequence, we investigated the methylation level of the SLC2A1 promoter at the pan-cancer level with TCGA data in UALCAN to investigate whether the abnormal expression level of SLC2A1 was related to DNA methylation. Here, SLC2A1 is linked to cancer.